Hims & Hers Health Inc
NYSE:HIMS
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.22
27.88
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one HIMS stock under the Base Case scenario is 12.24 USD. Compared to the current market price of 25.33 USD, Hims & Hers Health Inc is Overvalued by 52%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Hims & Hers Health Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for HIMS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Hims & Hers Health Inc
Balance Sheet Decomposition
Hims & Hers Health Inc
Current Assets | 326.4m |
Cash & Short-Term Investments | 254.1m |
Receivables | 4.6m |
Other Current Assets | 67.7m |
Non-Current Assets | 275.9m |
PP&E | 63m |
Intangibles | 157.5m |
Other Non-Current Assets | 55.3m |
Current Liabilities | 152.6m |
Accounts Payable | 75.4m |
Accrued Liabilities | 41.6m |
Other Current Liabilities | 35.6m |
Non-Current Liabilities | 9.6m |
Other Non-Current Liabilities | 9.6m |
Earnings Waterfall
Hims & Hers Health Inc
Revenue
|
1.2B
USD
|
Cost of Revenue
|
-234.3m
USD
|
Gross Profit
|
1B
USD
|
Operating Expenses
|
-962.8m
USD
|
Operating Income
|
44.9m
USD
|
Other Expenses
|
56.4m
USD
|
Net Income
|
101.3m
USD
|
Free Cash Flow Analysis
Hims & Hers Health Inc
USD | |
Free Cash Flow | USD |
Hims & Hers delivered a remarkable 77% year-over-year sales growth, surpassing $400 million in revenue for the third quarter. Adjusted EBITDA reached $51.1 million, reflecting a 13% margin. The company added over 180,000 new subscribers, totaling over 2 million. It anticipates Q4 revenues between $465 million and $470 million, representing a nearly 91% increase year-over-year. For the full year, expected sales range from $1.46 billion to $1.465 billion, a 67% increase. Moving forward, Hims & Hers plans significant capital investments to improve service capabilities and maximize customer retention through personalized solutions across multiple specialties.
What is Earnings Call?
HIMS Profitability Score
Profitability Due Diligence
Hims & Hers Health Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Hims & Hers Health Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
HIMS Solvency Score
Solvency Due Diligence
Hims & Hers Health Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Hims & Hers Health Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HIMS Price Targets Summary
Hims & Hers Health Inc
According to Wall Street analysts, the average 1-year price target for HIMS is 25.74 USD with a low forecast of 18.18 USD and a high forecast of 33.6 USD.
Dividends
Current shareholder yield for HIMS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
HIMS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 398 full-time employees. The company went IPO on 2019-09-09. The firm has designed and build a cloud-based technology, through which it offers a range of health and wellness products and services. Its platform helps customers to access medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more. The firm has partnered with dermatology experts to offer access to formulated topical creams for customers experiencing acne and signs of premature aging, such as wrinkles. The company offers telehealth solutions with combined access to a distributed provider network, digital prescriptions, cloud pharmacy, and consumer engagement strategies, all delivered through mobile and Web interfaces. The firm's Products include shampoo, conditioner, biotin gummies, anti-aging cream, vitamin c serum, acne cream and moisturizer.
Contact
IPO
Employees
Officers
The intrinsic value of one HIMS stock under the Base Case scenario is 12.24 USD.
Compared to the current market price of 25.33 USD, Hims & Hers Health Inc is Overvalued by 52%.